Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway
2008 ◽
Vol 40
(4)
◽
pp. 304-310
◽
2020 ◽
Vol 135
◽
pp. 110863
◽
Keyword(s):
2001 ◽
Vol 277
(5)
◽
pp. 3150-3157
◽
2010 ◽
Vol 54
(11)
◽
pp. 1696-1696
◽
2006 ◽
Vol 5
(3)
◽
pp. 494-501
◽
2014 ◽
Vol 125
(1)
◽
pp. 74-82
◽
Keyword(s):
Keyword(s):